MENDIRATTA; Sanjeev Kumar
Patent Applications and Registrations
Patent applications and USPTO patent grants for MENDIRATTA; Sanjeev Kumar.The latest application filed is for "antibodies to human programmed death receptor pd-1".
- MENDIRATTA; Sanjeev Kumar - Ahmedabad Gujarat
- Mendiratta; Sanjeev Kumar - Gujarat N/A IN
- MENDIRATTA; Sanjeev Kumar - US
| Patent | Date |
|---|---|
| Antibodies To Human Programmed Death Receptor Pd-1 App 20220289846 - MENDIRATTA; Sanjeev Kumar ; et al. | 2022-09-15 |
| Novel Protein Drug Conjugate Formulation App 20210330801 - MENDIRATTA; Sanjeev Kumar ; et al. | 2021-10-28 |
| Pharmaceutical Formulations Of Tnf-alpha Antibodies App 20190071496 - Mendiratta; Sanjeev Kumar ; et al. | 2019-03-07 |
| Process Of Preparing Antibody-drug Conjugate App 20180311375 - MENDIRATTA; Sanjeev Kumar ; et al. | 2018-11-01 |
| Pharmaceutical formulations of TNF-alpha antibodies Grant 10,093,728 - Mendiratta , et al. October 9, 2 | 2018-10-09 |
| Purification process for monoclonal antibodies Grant 9,708,365 - Mendiratta , et al. July 18, 2 | 2017-07-18 |
| Novel Purification Process Of Gonadotropin App 20170029482 - Mendiratta; Sanjeev Kumar ; et al. | 2017-02-02 |
| Improved Process For Production Of Monoclonal Antibodies App 20160215319 - MENDIRATTA; Sanjeev Kumar ; et al. | 2016-07-28 |
| Purification Process for PTH App 20160200792 - Mendiratta; Sanjeev Kumar ; et al. | 2016-07-14 |
| Purification Process For Monoclonal Antibodies App 20160115195 - Mendiratta; Sanjeev Kumar ; et al. | 2016-04-28 |
| Process for the purification of tissue plasminogen activator Grant 9,175,281 - Bandyopadhyay , et al. November 3, 2 | 2015-11-03 |
| Pharmaceutical Formulations Of Tnf-alpha Antibodies App 20150071936 - Mendiratta; Sanjeev Kumar ; et al. | 2015-03-12 |
| Enzyme For The Production Of Optically Pure 3-quinuclidinol App 20140147896 - Joshi; Rupal ; et al. | 2014-05-29 |
| Novel Process For The Purification Of Tissue Plasminogen Activator App 20130330808 - Bandyopadhyay; Sanjay ; et al. | 2013-12-12 |
| Expression Vector For High Level Expression Of Recombinant Proteins App 20130244280 - Parikh; Aashini ; et al. | 2013-09-19 |
| Process for preparing human G-CSF Grant 8,492,120 - Mendiratta , et al. July 23, 2 | 2013-07-23 |
| Formulations of PEG-interferon alpha conjugates Grant 8,367,054 - Bandyopadhyay , et al. February 5, 2 | 2013-02-05 |
| Process for preparing human G-CSF Grant 8,021,862 - Mendiratta , et al. September 20, 2 | 2011-09-20 |
| Process for preparing high levels of interferon beta Grant 7,923,220 - Mendiratta , et al. April 12, 2 | 2011-04-12 |
| Process For Preparing Human G-csf App 20110070611 - MENDIRATTA; Sanjeev Kumar ; et al. | 2011-03-24 |
| Process For Preparing Human G-csf App 20090305354 - Mendiratta; Sanjeev Kumar ; et al. | 2009-12-10 |
| Process for Preparing High Levels of Interferon Beta App 20090215121 - Mendiratta; Sanjeev Kumar ; et al. | 2009-08-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 